Revive Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Mar 24 | Buy€2,375 | Michael Frank | Individual | 100,000 | €0.024 | |
18 Mar 24 | Buy€3,565 | Michael Frank | Individual | 150,000 | €0.024 | |
15 Mar 24 | Buy€6,556 | Michael Frank | Individual | 322,000 | €0.02 |
Insider Trading Volume
Insider Buying: 31R insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 160,845 | 0.0384% |
Individual Insiders | 6,119,534 | 1.46% |
General Public | 412,283,890 | 98.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,638,500 | €54.0k | 27.7% | no data | |||
2,000,000 | €41.0k | 0% | no data | |||
650,000 | €13.3k | 0% | no data | |||
625,334 | €12.8k | 0% | no data | |||
205,700 | €4.2k | 0% | no data | |||
125,000 | €2.6k | 0% | no data | |||
25,000 | €511.8 | 0% | no data | |||
10,345 | €211.7 | 0% | no data | |||
500 | €10.3 | 0% | no data |